TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN

AC T25008 XX ID T25008 XX DT 10.03.2005 (created); nvo. DT 27.02.2015 (updated); ros. CO Copyright (C), QIAGEN. XX FA pRb XX SY p105-RB; pp110; Rb; retinoblastoma tumor suppressor protein; retinoblastoma-associated protein. XX OS Mammalia OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia XX IN T23080 AhR; Mammalia. IN T08443 AML3; mouse, Mus musculus. IN T09552 AML3; Mammalia. IN T15601 AR; Mammalia. IN T15974 Ben; Mammalia. IN T08887 brca1-isoform1; human, Homo sapiens. IN T04074 brca1; human, Homo sapiens. IN T16987 BRG1; Mammalia. IN T09446 c-Jun; Mammalia. IN T14435 c-Myc; Mammalia. IN T09410 C/EBPbeta; Mammalia. IN T10007 CDP; Mammalia. IN T25729 Dnmt1-isoform1; human, Homo sapiens. IN T01542 E2F-1; human, Homo sapiens. IN T09117 E2F-1; human, Homo sapiens. IN T09570 E2F-1; Mammalia. IN T17403 E2F-2; Mammalia. IN T17404 E2F-3; Mammalia. IN T10751 E2F-4; Mammalia. IN T14623 Ebp1; Mammalia. IN T10659 Elf-1; Mammalia. IN T16493 hbp1; Mammalia. IN T08343 HDAC1; human, Homo sapiens. IN T21852 HDAC1; Mammalia. IN T23418 HDAC1; mouse, Mus musculus. IN T04110 HDAC3; human, Homo sapiens. IN T09895 HES-1; human, Homo sapiens. IN T09897 HES-1; rat, Rattus norvegicus. IN T15694 Id2; Mammalia. IN T15348 Ikaros; Mammalia. IN T34277 mcm7; human, Homo sapiens. IN T22586 N-Myc; Mammalia. IN T14436 NeuroD-1; Mammalia. IN T17526 pax-2; Mammalia. IN T10279 Pax-3; Mammalia. IN T10303 Pax-5; Mammalia. IN T14288 PLZF; Mammalia. IN T10037 PU.1; Mammalia. IN T10429 PU.1; mouse, Mus musculus. IN T14264 RBTN2; Mammalia. IN T14175 TBP; Mammalia. IN T31844 topoisomerase-II-alpha; human, Homo sapiens. IN T09133 YY1; Mammalia. XX BS R39641. XX DR TRANSPATH: MO000047492. XX RN [1]; RE0002718. RX PUBMED: 8493578. RA Wang C.-Y., Petryniak B., Thompson C. B., Kaelin W. G., Leiden J. M. RT Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein RL Science 260:1330-1335 (1993). RN [2]; RE0003302. RX PUBMED: 8405995. RA Helin K., Wu C. L., Fattaey A. R., Lees J. A., Dynlacht B. D., Ngwu C., Harlow E. RT Heterodimerization of the transcription factors E2F1 and DP-1 leads to cooperative trans-activation RL Genes Dev. 7:1850-1861 (1993). RN [3]; RE0003339. RX PUBMED: 1436095. RA Goodrich D. W., Lee W.-H. RT Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53 RL Nature 360:177-179 (1992). RN [4]; RE0006427. RX PUBMED: 8876167. RA van Wijnen A. J., van Gurp M. F., de Ripper M. C., Tufarelli C., Last T. J., Birnbaum M., Vaughan P. S., Giordano A., Krek W., Neufeld E. J., Stein J. L., Stein G. S. RT CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: A mechanism for gene regulation at the G1/s phase cell cycle transition point independent of transcription factor E2F RL Proc. Natl. Acad. Sci. USA 93:11516-11521 (1996). RN [5]; RE0011309. RX PUBMED: 7673249. RA Inoue A., Torigoe T., Sogahata K., Kamiguchi K., Takahashi S., Sawada Y., Saijo M., Taya Y., Ishii S., Sato N., Kikuchi K. RT 70-kDa heat shock cognate protein interacts directly with the N-terminal region of the retinoblastoma gene product pRb RL J. Biol. Chem. 270:22571-22576 (1995). RN [6]; RE0012417. RX PUBMED: 8756626. RA Chen C.-C., Chen Y., Dai K., Chen P.-L., Riley D. J., Lee W.-H. RT A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock RL Mol. Cell. Biol. 16:4691-4699 (1996). RN [7]; RE0014085. RX PUBMED: 9464541. RA Wiggan O., Taniguchi-Sidle A., Hamel P. A. RT Interaction of the pRB-family proteins with factors containing paired-like homeodomains RL Oncogene 16:227-236 (1998). RN [8]; RE0015427. RX PUBMED: 10779352. RA Leone G., Nuckolls F., Ishida S., Adams M., Sears R., Jakoi L., Miron A., Nevins J. R. RT Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins RL Mol. Cell. Biol. 20:3626-3632 (2000). RN [9]; RE0017984. RX PUBMED: 10330185. RA Tamir A., Howard J., Higgins R. R., Li Y. J., Berger L., Zacksenhaus E., Reis M., Ben-David Y. RT Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. RL Mol. Cell. Biol. 19:4452-4464 (1999). RN [10]; RE0021063. RX PUBMED: 9819434. RA Wang S., Ghosh R. N., Chellappan S. P. RT Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulation RL Mol. Cell. Biol. 18:7487-7498 (1998). RN [11]; RE0021446. RX PUBMED: 10866689. RA Vitelli L., Condorelli G., Lulli V., Hoang T., Luchetti L., Croce C. M., Peschle C. RT A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts RL Mol. Cell. Biol. 20:5330-5342 (2000). RN [12]; RE0022510. RX PUBMED: 11259609. RA Elferink C. J., Ge N. L., Levine A. RT Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. RL Mol. Pharmacol. 59:664-673 (2001). RN [13]; RE0026750. RX PUBMED: 10982822. RA Wu L., Goodwin E. C., Naeger L. K., Vigo E., Galaktionov K., Helin K., DiMaio D. RT E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression. RL Mol. Cell. Biol. 20:7059-67 (2000). RN [14]; RE0027276. RX PUBMED: 11126356. RA Siegert J. L., Rushton J. J., Sellers W. R., Kaelin W. G. Jr, Robbins P. D. RT Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity. RL Oncogene 19:5703-11 (2000). RN [15]; RE0027396. RX PUBMED: 10734134. RA Nicolas E., Morales V., Magnaghi-Jaulin L., Harel-Bellan A., Richard-Foy H., Trouche D. RT RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein. RL J. Biol. Chem. 275:9797-804 (2000). RN [16]; RE0028058. RX PUBMED: 11500496. RA Leung J. K., Berube N., Venable S., Ahmed S., Timchenko N., Pereira-Smith O. M. RT MRG15 activates the B-myb promoter through formation of a nuclear complex with the retinoblastoma protein and the novel protein PAM14. RL J. Biol. Chem. 276:39171-8 (2001). RN [17]; RE0028711. RX PUBMED: 11484059. RA Nielsen S. J., Schneider R., Bauer U. M., Bannister A. J., Morrison A., O'Carroll D., Firestein R., Cleary M., Jenuwein T., Herrera R. E., Kouzarides T. RT Rb targets histone H3 methylation and HP1 to promoters. RL Nature 412:561-5 (2001). RN [18]; RE0029146. RX PUBMED: 11884439. RA Appleman L. J., van Puijenbroek A. A., Shu K. M., Nadler L. M., Boussiotis V. A. RT CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. RL J. Immunol. 168:2729-36 (2002). RN [19]; RE0029518. RX PUBMED: 12101225. RA Ryo A., Liou Y. C., Wulf G., Nakamura M., Lee S. W., Lu K. P. RT PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. RL Mol. Cell. Biol. 22:5281-95 (2002). RN [20]; RE0030014. RX PUBMED: 12391156. RA Decary S., Decesse J. T., Ogryzko V., Reed J. C., Naguibneva I., Harel-Bellan A., Cremisi C. E. RT The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. RL Mol. Cell. Biol. 22:7877-88 (2002). RN [21]; RE0030221. RX PUBMED: 12475961. RA Markiewicz E., Dechat T., Foisner R., Quinlan R. A., Hutchison C. J. RT Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein. RL Mol. Biol. Cell 13:4401-13 (2002). RN [22]; RE0031317. RX PUBMED: 12527885. RA Berkovich E., Ginsberg D. RT ATM is a target for positive regulation by E2F-1. RL Oncogene 22:161-7 (2003). RN [23]; RE0031711. RX PUBMED: 11684023. RA Puri P. L., Iezzi S., Stiegler P., Chen T. T., Schiltz R. L., Muscat G. E., Giordano A., Kedes L., Wang J. Y., Sartorelli V. RT Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. RL Mol. Cell 8:885-97 (2001). RN [24]; RE0031862. RX PUBMED: 12769842. RA Yang H. S., Hinds P. W. RT Increased ezrin expression and activation by CDK5 coincident with acquisition of the senescent phenotype. RL Mol. Cell 11:1163-76 (2003). RN [25]; RE0031977. RX PUBMED: 12588994. RA Diehl J. A., Yang W., Rimerman R. A., Xiao H., Emili A. RT Hsc70 regulates accumulation of cyclin D1 and cyclin D1-dependent protein kinase. RL Mol. Cell. Biol. 23:1764-74 (2003). RN [26]; RE0032005. RX PUBMED: 9448006. RA Alcalay M., Tomassoni L., Colombo E., Stoldt S., Grignani F., Fagioli M., Szekely L., Helin K., Pelicci P. G. RT The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. RL Mol. Cell. Biol. 18:1084-93 (1998). RN [27]; RE0032026. RX PUBMED: 11959865. RA Koipally J., Georgopoulos K. RT Ikaros-CtIP interactions do not require C-terminal binding protein and participate in a deacetylase-independent mode of repression. RL J. Biol. Chem. 277:23143-9 (2002). RN [28]; RE0032121. RX PUBMED: 12543798. RA Tashiro E., Maruki H., Minato Y., Doki Y., Weinstein I. B., Imoto M. RT Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway. RL Cancer Res. 63:424-31 (2003). RN [29]; RE0032223. RX PUBMED: 14729647. RA Ji Y., Studzinski G. P. RT Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells. RL Cancer Res. 64:370-7 (2004). RN [30]; RE0032236. RX PUBMED: 9343416. RA Bash J., Zong W. X., Gelinas C. RT c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. RL Mol. Cell. Biol. 17:6526-36 (1997). RN [31]; RE0032299. RX PUBMED: 7889981. RA Yen A., Williams M., Platko J. D., Der C., Hisaka M. RT Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation. RL Eur. J. Cell Biol. 65:103-13 (1994). RN [32]; RE0032919. RX PUBMED: 15215046. RA Lakshman M., Subramaniam V., Rubenthiran U., Jothy S. RT CD44 promotes resistance to apoptosis in human colon cancer cells. RL Exp. Mol. Pathol. 77:18-25 (2004). RN [33]; RE0034338. RX PUBMED: 15210709. RA Dasgupta P., Betts V., Rastogi S., Joshi B., Morris M., Brennan B., Ordonez-Ercan D., Chellappan S. RT Direct binding of apoptosis signal-regulating kinase 1 to retinoblastoma protein: novel links between apoptotic signaling and cell cycle machinery. RL J. Biol. Chem. 279:38762-9 (2004). RN [34]; RE0036251. RX PUBMED: 10944455. RA Wen H., Ao S. RT RBP95, a novel leucine zipper protein, binds to the retinoblastoma protein RL Biochem. Biophys. Res. Commun. 275:141-8 (2000). RN [35]; RE0036283. RX PUBMED: 12716909. RA Chung H. K., Yi Y. W., Jung N. C., Kim D., Suh J. M., Kim H., Park K. C., Song J. H., Kim D. W., Hwang E. S., Yoon S. H., Bae Y. S., Kim J. M., Bae I., Shong M. RT CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle RL J. Biol. Chem. 278:28079-88 (2003). RN [36]; RE0036304. RX PUBMED: 11390653. RA Pestov D. G., Strezoska Z., Lau L. F. RT Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition RL Mol. Cell. Biol. 21:4246-55 (2001). RN [37]; RE0036577. RX PUBMED: 10049565. RA Yuan S. S., Cox L. A., Dasika G. K., Lee E. Y. RT Cloning and functional studies of a novel gene aberrantly expressed in RB-deficient embryos RL Dev. Biol. 207:62-75 (1999). RN [38]; RE0036579. RX PUBMED: 12200151. RA Yuan S. S., Yeh Y. T., Lee E. Y. RT Pax-2 interacts with RB and reverses its repression on the promoter of Rig-1, a Robo member RL Biochem. Biophys. Res. Commun. 296:1019-25 (2002). RN [39]; RE0036673. RX PUBMED: 12629508. RA Wells J., Yan P. S., Cechvala M., Huang T., Farnham P. J. RT Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase RL Oncogene 22:1445-60 (2003). RN [40]; RE0036698. RX PUBMED: 12027450. RA Angus S. P., Fribourg A. F., Markey M. P., Williams S. L., Horn H. F., DeGregori J., Kowalik T. F., Fukasawa K., Knudsen E. S. RT Active RB elicits late G1/S inhibition RL Exp. Cell Res. 276:201-13 (2002). RN [41]; RE0036800. RX PUBMED: 11980674. RA Pidgeon G. P., Kandouz M., Meram A., Honn K. V. RT Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells RL Cancer Res. 62:2721-7 (2002). RN [42]; RE0036841. RX PUBMED: 10783144. RA Fanciulli M., Bruno T., Di Padova M., De Angelis R., Iezzi S., Iacobini C., Floridi A., Passananti C. RT Identification of a novel partner of RNA polymerase II subunit 11, Che-1, which interacts with and affects the growth suppression function of Rb RL FASEB J. 14:904-12 (2000). RN [43]; RE0036859. RX PUBMED: 10613832. RA Higashitsuji H., Itoh K., Nagao T., Dawson S., Nonoguchi K., Kido T., Mayer R. J., Arii S., Fujita J. RT Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas RL Nat. Med. 6:96-9 (2000). RN [44]; RE0036868. RX PUBMED: 11113200. RA Wu L., Chen P., Shum C. H., Chen C., Barsky L. W., Weinberg K. I., Jong A., Triche T. J. RT MAT1-Modulated CAK activity regulates cell cycle G(1) exit RL Mol. Cell. Biol. 21:260-70 (2001). RN [45]; RE0037331. RX PUBMED: 9697699. RA Woitach J. T., Zhang M., Niu C. H., Thorgeirsson S. S. RT A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability RL Nat. Genet. 19:371-4 (1998). RN [46]; RE0037431. RX PUBMED: 10675335. RA Martinez-Balbas M. A., Bauer U. M., Nielsen S. J., Brehm A., Kouzarides T. RT Regulation of E2F1 activity by acetylation RL EMBO J. 19:662-71 (2000). RN [47]; RE0037435. RX PUBMED: 12947005. RA Gery S., Gombart A. F., Fung Y. K., Koeffler H. P. RT C/EBPepsilon interacts with retinoblastoma and E2F1 during granulopoiesis RL Blood 103:828-35 (2004). RN [48]; RE0037535. RX PUBMED: 10702291. RA Skapek S. X., Jansen D., Wei T. F., McDermott T., Huang W., Olson E. N., Lee E. Y. RT Cloning and characterization of a novel Kruppel-associated box family transcriptional repressor that interacts with the retinoblastoma gene product, RB RL J. Biol. Chem. 275:7212-23 (2000). RN [49]; RE0037744. RX PUBMED: 8649364. RA Lasorella A., Iavarone A., Israel M. A. RT Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins RL Mol. Cell. Biol. 16:2570-8 (1996). RN [50]; RE0037778. RX PUBMED: 9566894. RA Sterner J. M., Dew-Knight S., Musahl C., Kornbluth S., Horowitz J. M. RT Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7 RL Mol. Cell. Biol. 18:2748-57 (1998). RN [51]; RE0038111. RX PUBMED: 12759432. RA Gordon S. J., Saleque S., Birshtein B. K. RT Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3' Igh enhancer, hs3 RL J. Immunol. 170:5549-57 (2003). RN [52]; RE0038622. RX PUBMED: 11118353. RA Chang M. S., Chang C. L., Huang C. J., Yang Y. C. RT p29, a Novel GCIP-Interacting Protein, Localizes in the Nucleus RL Biochem. Biophys. Res. Commun. 279:732-737 (2000). RN [53]; RE0038952. RX PUBMED: 8242749. RA Welch P. J., Wang J. Y. RT A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle RL Cell 75:779-90 (1993). RN [54]; RE0039086. RX PUBMED: 9774636. RA Yamabe Y., Shimamoto A., Goto M., Yokota J., Sugawara M., Furuichi Y. RT Sp1-mediated transcription of the Werner helicase gene is modulated by Rb and p53 RL Mol. Cell. Biol. 18:6191-200 (1998). RN [55]; RE0039088. RX PUBMED: 11114723. RA Krucher N. A., Zygmunt A., Mazloum N., Tamrakar S., Ludlow J. W., Lee M. Y. RT Interaction of the retinoblastoma protein (pRb) with the catalytic subunit of DNA polymerase delta (p125) RL Oncogene 19:5464-70 (2000). RN [56]; RE0039092. RX PUBMED: 11545733. RA Thomas D. M., Carty S. A., Piscopo D. M., Lee J., Wang W., Forrester W. C., Hinds P. W. RT The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation RL Mol. Cell 8:303-16 (2001). RN [57]; RE0039260. RX PUBMED: 12845674. RA Arhel N. J., Packham G., Townsend P. A., Collard T. J., H-Zadeh A. M., Sharp A., Cutress R. I., Malik K., Hague A., Paraskeva C., Williams A. C. RT The retinoblastoma protein interacts with Bag-1 in human colonic adenoma and carcinoma derived cell lines RL Int. J. Cancer 106:364-71 (2003). RN [58]; RE0039441. RX PUBMED: 10642537. RA Yan X., Zhao X., Qian M., Guo N., Gong X., Zhu X. RT Characterization and gene structure of a novel retinoblastoma-protein-associated protein similar to the transcription regulator TFII-I RL Biochem. J. 345:749-57 (2000). RN [59]; RE0039448. RX PUBMED: 12169636. RA Smogorzewska A., de Lange T. RT Different telomere damage signaling pathways in human and mouse cells RL EMBO J. 21:4338-48 (2002). RN [60]; RE0039452. RX PUBMED: 12210730. RA Cui Y., Mirkia K., Florence Fu Y. H., Zhu L., Yokoyama K. K., Chiu R. RT Interaction of the retinoblastoma gene product, RB, with cyclophilin A negatively affects cyclosporin-inhibited NFAT signaling RL J. Cell. Biochem. 86:630-41 (2002). RN [61]; RE0039639. RX PUBMED: 12944478. RA Darnell G. A., Antalis T. M., Johnstone R. W., Stringer B. W., Ogbourne S. M., Harrich D., Suhrbier A. RT Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif RL Mol. Cell. Biol. 23:6520-32 (2003). RN [62]; RE0039640. RX PUBMED: 9235941. RA Fan G., Ma X., Kren B. T., Rice M., Kmiec E. B., Steer C. J. RT A novel link between REC2, a DNA recombinase, the retinoblastoma protein, and apoptosis RL J. Biol. Chem. 272:19413-7 (1997). RN [63]; RE0039681. RX PUBMED: 9566959. RA Kim T. A., Lim J., Ota S., Raja S., Rogers R., Rivnay B., Avraham H., Avraham S. RT NRP/B, a novel nuclear matrix protein, associates with p110(RB) and is involved in neuronal differentiation RL J. Cell Biol. 141:553-66 (1998). RN [64]; RE0039703. RX PUBMED: 10799486. RA Shim J., Park H. S., Kim M. J., Park J., Park E., Cho S. G., Eom S. J., Lee H. W., Joe C. O., Choi E. J. RT Rb protein down-regulates the stress-activated signals through inhibiting c-Jun N-terminal kinase/stress-activated protein kinase RL J. Biol. Chem. 275:14107-11 (2000). RN [65]; RE0039705. RX PUBMED: 10026157. RA Nishitani J., Nishinaka T., Cheng C. H., Rong W., Yokoyama K. K., Chiu R. RT Recruitment of the retinoblastoma protein to c-Jun enhances transcription activity mediated through the AP-1 binding site RL J. Biol. Chem. 274:5454-61 (1999). RN [66]; RE0039706. RX PUBMED: 12027453. RA Takemura M., Ohoka F., Perpelescu M., Ogawa M., Matsushita H., Takaba T., Akiyama T., Umekawa H., Furuichi Y., Cook P. R., Yoshida S. RT Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23 RL Exp. Cell Res. 276:233-41 (2002). RN [67]; RE0039744. RX PUBMED: 10880954. RA Lopez-Marure R., Ventura J. L., Sanchez L., Montano L. F., Zentella A. RT Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels RL Eur. J. Biochem. 267:4325-33 (2000). RN [68]; RE0039746. RX PUBMED: 9813067. RA Lu J., Danielsen M. RT Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein RL J. Biol. Chem. 273:31528-33 (1998). RN [69]; RE0039747. RX PUBMED: 9675141. RA Yeh S., Miyamoto H., Nishimura K., Kang H., Ludlow J., Hsiao P., Wang C., Su C., Chang C. RT Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells RL Biochem. Biophys. Res. Commun. 248:361-7 (1998). RN [70]; RE0039753. RX PUBMED: 1857421. RA Defeo-Jones D., Huang P. S., Jones R. E., Haskell K. M., Vuocolo G. A., Hanobik M. G., Huber H. E., Oliff A. RT Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product RL Nature 352:251-4 (1991). RN [71]; RE0039754. RX PUBMED: 7923370. RA Dunaief J. L., Strober B. E., Guha S., Khavari P. A., Alin K., Luban J., Begemann M., Crabtree G. R., Goff S. P. RT The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest RL Cell 79:119-30 (1994). RN [72]; RE0039758. RX PUBMED: 12682367. RA Zhang Y., Woodford N., Xia X., Hamburger A. W. RT Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases RL Nucleic Acids Res. 31:2168-77 (2003). RN [73]; RE0039774. RX PUBMED: 9892014. RA Sharma K., Patel Y. C., Srikant C. B. RT C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest RL Mol. Endocrinol. 13:82-90 (1999). RN [74]; RE0039842. RX PUBMED: 9010216. RA Simons A., Melamed-Bessudo C., Wolkowicz R., Sperling J., Sperling R., Eisenbach L., Rotter V. RT PACT: cloning and characterization of a cellular p53 binding protein that interacts with Rb RL Oncogene 14:145-55 (1997). RN [75]; RE0039900. RX PUBMED: 10393912. RA Bhat U. G., Raychaudhuri P., Beck W. T. RT Functional interaction between human topoisomerase IIalpha and retinoblastoma protein RL Proc. Natl. Acad. Sci. USA 96:7859-64 (1999). RN [76]; RE0039907. RX PUBMED: 11268000. RA Xia X., Cheng A., Lessor T., Zhang Y., Hamburger A. W. RT Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation RL J. Cell. Physiol. 187:209-17 (2001). RN [77]; RE0039909. RX PUBMED: 12221087. RA Angus S. P., Wheeler L. J., Ranmal S. A., Zhang X., Markey M. P., Mathews C. K., Knudsen E. S. RT Retinoblastoma tumor suppressor targets dNTP metabolism to regulate DNA replication RL J. Biol. Chem. 277:44376-84 (2002). RN [78]; RE0039915. RX PUBMED: 12749855. RA Joulia D., Bernardi H., Garandel V., Rabenoelina F., Vernus B., Cabello G. RT Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin RL Exp. Cell Res. 286:263-75 (2003). RN [79]; RE0040002. RX PUBMED: 11146559. RA Liu Y., Zacksenhaus E. RT E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses RL Oncogene 19:6065-73 (2000). RN [80]; RE0040019. RX PUBMED: 8227169. RA Yen A., Forbes M. E., Varvayanis S., Tykocinski M. L., Groger R. K., Platko J. D. RT C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression RL J. Cell. Physiol. 157:379-91 (1993). RN [81]; RE0040020. RX PUBMED: 10437913. RA Zhang H., Shepherd A. T., Eason D. D., Wei S., Diaz J. I., Djeu J. Y., Wu G. D., Blanck G. RT Retinoblastoma protein expression leads to reduced Oct-1 DNA binding activity and enhances interleukin-8 expression RL Cell Growth Differ. 10:457-65 (1999). RN [82]; RE0040086. RX PUBMED: 10918607. RA Hannan K. M., Kennedy B. K., Cavanaugh A. H., Hannan R. D., Hirschler-Laszkiewicz I., Jefferson L. S., Rothblum L. I. RT RNA polymerase I transcription in confluent cells: Rb downregulates rDNA transcription during confluence-induced cell cycle arrest RL Oncogene 19:3487-97 (2000). RN [83]; RE0040089. RX PUBMED: 10454440. RA Aoki M., Morishita R., Matsushita H., Hayashi S., Nakagami H., Yamamoto K., Moriguchi A., Kaneda Y., Higaki J., Ogihara T. RT Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth RL Hypertension 34:192-200 (1999). RN [84]; RE0040106. RX PUBMED: 8822942. RA Urashima M., Ogata A., Chauhan D., Vidriales M. B., Teoh G., Hoshi Y., Schlossman R. L., DeCaprio J. A., Anderson K. C. RT Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein RL Blood 88:2219-27 (1996). RN [85]; RE0040202. RX PUBMED: 11223246. RA Wen H., Ao S. RT Identification and characterization of a novel human cDNA encoding a 21 kDa pRb-associated protein RL Gene 263:85-92 (2001). RN [86]; RE0040205. RX PUBMED: 7997248. RA Lu Y., Ussery G. D., Jacim M., Tschickardt M., Boss J. M., Blanck G. RT Retinoblastoma protein regulation of surface CD74 (invariant chain) expression in breast carcinoma cells RL Mol. Immunol. 31:1365-8 (1994). RN [87]; RE0040207. RX PUBMED: 9671483. RA Shih H. H., Tevosian S. G., Yee A. S. RT Regulation of differentiation by HBP1, a target of the retinoblastoma protein RL Mol. Cell. Biol. 18:4732-43 (1998). RN [88]; RE0040212. RX PUBMED: 7525595. RA Durfee T., Mancini M. A., Jones D., Elledge S. J., Lee W. H. RT The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing RL J. Cell Biol. 127:609-22 (1994). RN [89]; RE0040219. RX PUBMED: 10889204. RA Tamrakar S., Ludlow J. W. RT The carboxyl-terminal region of the retinoblastoma protein binds non-competitively to protein phosphatase type 1alpha and inhibits catalytic activity RL J. Biol. Chem. 275:27784-9 (2000). RN [90]; RE0040356. RX PUBMED: 10825186. RA Flatt P. M., Tang L. J., Scatena C. D., Szak S. T., Pietenpol J. A. RT p53 regulation of G(2) checkpoint is retinoblastoma protein dependent RL Mol. Cell. Biol. 20:4210-23 (2000). RN [91]; RE0040369. RX PUBMED: 9784414. RA Omura T., Yano Y., Hasuma T., Kinoshita H., Matsui-Yuasa I., Otani S. RT Involvement of polyamines in retinoblastoma protein phosphorylation RL Biochem. Biophys. Res. Commun. 250:731-4 (1998). RN [92]; RE0040371. RX PUBMED: 9453002. RA Terada Y., Inoshita S., Nakashima O., Yamada T., Tamamori M., Ito H., Sasaki S., Marumo F. RT Cyclin D1, p16, and retinoblastoma gene regulate mitogenic signaling of endothelin in rat mesangial cells RL Kidney Int. 53:76-83 (1998). RN [93]; RE0041095. RX PUBMED: 9710587. RA Veal E., Eisenstein M., Tseng Z. H., Gill G. RT A cellular repressor of E1A-stimulated genes that inhibits activation by E2F RL Mol. Cell. Biol. 18:5032-41 (1998). RN [94]; RE0042688. RX PUBMED: 11684017. RA Wang H., Iakova P., Wilde M., Welm A., Goode T., Roesler W. J., Timchenko N. A. RT C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4 RL Mol. Cell 8:817-28 (2001). RN [95]; RE0044617. RX PUBMED: 11094070. RA Hirsch H. A., Gu L., Henry R. W. RT The retinoblastoma tumor suppressor protein targets distinct general transcription factors to regulate RNA polymerase III gene expression RL Mol. Cell. Biol. 20:9182-91 (2000). RN [96]; RE0046973. RX PUBMED: 12525503. RA Nagao T., Higashitsuji H., Nonoguchi K., Sakurai T., Dawson S., Mayer R. J., Itoh K., Fujita J. RT MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity RL J. Biol. Chem. 278:10668-74 (2003). RN [97]; RE0047311. RX PUBMED: 9256431. RA Chang K. H., Chen Y., Chen T. T., Chou W. H., Chen P. L., Ma Y. Y., Yang-Feng T. L., Leng X., Tsai M. J., O'Malley B. W., Lee W. H. RT A thyroid hormone receptor coactivator negatively regulated by the retinoblastoma protein RL Proc. Natl. Acad. Sci. USA 94:9040-5 (1997). RN [98]; RE0047443. RX PUBMED: 12473678. RA Kimura H., Shiota K. RT Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. RL J. Biol. Chem. 278:4806-4812 (2003). RN [99]; RE0047542. RX PUBMED: 9724731. RA Ferreira R., Magnaghi-Jaulin L., Robin P., Harel-Bellan A., Trouche D. RT The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. RL Proc. Natl. Acad. Sci. USA 95:10493-10498 (1998). RN [100]; RE0048134. RX PUBMED: 10196196. RA Rao S., Matsumura A., Yoon J., Simon M. C. RT SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1. RL J. Biol. Chem. 274:11115-11124 (1999). RN [101]; RE0048167. RX PUBMED: 15701640. RA Batsche E., Moschopoulos P., Desroches J., Bilodeau S., Drouin J. RT Retinoblastoma and the related pocket protein p107 act as coactivators of NeuroD1 to enhance gene transcription. RL J. Biol. Chem. 280:16088-16095 (2005). RN [102]; RE0048205. RX PUBMED: 10220405. RA Yarden R. I., Brody L. C. RT BRCA1 interacts with components of the histone deacetylase complex. RL Proc. Natl. Acad. Sci. USA 96:4983-4988 (1999). RN [103]; RE0048954. RX PUBMED: 16753023. RA Lee J. S., Thomas D. M., Gutierrez G., Carty S. A., Yanagawa S., Hinds P. W. RT HES1 cooperates with pRb to activate RUNX2-dependent transcription. RL J. Bone Miner. Res. 21:921-933 (2006). RN [104]; RE0051076. RX PUBMED: 16091739. RA Xiao H., Goodrich D. W. RT The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes. RL Oncogene 24:8105-8113 (2005). RN [105]; RE0052243. RX PUBMED: 10615135. RA Fuks F., Burgers W. A., Brehm A., Hughes-Davies L., Kouzarides T. RT DNA methyltransferase Dnmt1 associates with histone deacetylase activity. RL Nat. Genet. 24:88-91 (2000). RN [106]; RE0052309. RX PUBMED: 10490602. RA Lai A., Lee J. M., Yang W. M., DeCaprio J. A., Kaelin WG J. r., Seto E., Branton P. E. RT RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. RL Mol. Cell. Biol. 19:6632-6641 (1999). RN [107]; RE0052561. RX PUBMED: 11285237. RA Mal A., Sturniolo M., Schiltz R. L., Ghosh M. K., Harter M. L. RT A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. RL EMBO J. 20:1739-1753 (2001). RN [108]; RE0053042. RX PUBMED: 10888886. RA Robertson K. D., Ait-Si-Ali S., Yokochi T., Wade P. A., Jones P. L., Wolffe A. P. RT DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. RL Nat. Genet. 25:338-342 (2000). RN [109]; RE0053227. RX PUBMED: 10491434. RA Yarbrough W. G., Buckmire R. A., Bessho M., Liu E. T. RT Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors. RL J. Natl. Cancer Inst. 91:1569-1574 (1999). RN [110]; RE0053306. RX PUBMED: 11003668. RA Nishiwaki E., Turner S. L., Harju S., Miyazaki S., Kashiwagi M., Koh J., Serizawa H. RT Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation. RL Mol. Cell. Biol. 20:7726-7734 (2000). RN [111]; RE0054772. RX PUBMED: 17689131. RA Humar M., Loop T., Schmidt R., Hoetzel A., Roesslein M., Andriopoulos N., Pahl H. L., Geiger K. K., Pannen B. H. RT The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun. RL Int. J. Biochem. Cell Biol. 39:2278-2288 (2007). RN [112]; RE0056060. RX PUBMED: 17038621. RA Huang H., Regan K. M., Lou Z., Chen J., Tindall D. J. RT CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage. RL Science 314:294-297 (2006). RN [113]; RE0069339. RX PUBMED: 20668449. RA Tooley C. E., Petkowski J. J., Muratore-Schroeder T. L., Balsbaugh J. L., Shabanowitz J., Sabat M., Minor W., Hunt D. F., Macara I. G. RT NRMT is an alpha-N-methyltransferase that methylates RCC1 and retinoblastoma protein. RL Nature 466:1125-1128 (2010). XX //